2/22/21 19:40  | 2/22/21  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 827 | 165.30 | 0 | 5 | 1 | 496 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/1/20 18:05  | 8/31/20  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 875 | 174.99 | 0 | 5 | 1 | 456 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/11/20 20:38  | 8/11/20  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 1,171 | 234.12 | 0 | 5 | 1 | 451 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/12/20 17:53  | 6/11/20  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 802 | 160.33 | 0 | 5 | 1 | 446 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/22/19 20:03  | 11/20/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 8,470 | 22.42 | 0 | 378 | 767 | 427 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/30/19 20:00  | 8/28/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 1,089 | 15.19 | 0 | 72 | 31 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/30/19 20:00  | 8/28/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -4,459 | 62.18 | 0 | -72 | -19 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/19 20:04  | 7/29/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 331 | 15.19 | 0 | 22 | 8 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/19 20:04  | 7/29/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.d | -1,259 | 57.78 | 0 | -22 | -7 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/28/19 19:59  | 6/26/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 421 | 14.67 | 0 | 29 | 11 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/28/19 19:59  | 6/26/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,653 | 57.59 | 0 | -29 | -9 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/29/19 20:13  | 3/27/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 319 | 12.63 | 0 | 25 | 9 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/29/19 20:13  | 3/27/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,657 | 65.64 | 0 | -25 | -8 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/19 20:02  | 2/26/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 1,012 | 13.36 | 0 | 76 | 34 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/19 20:02  | 2/26/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -4,982 | 65.77 | 0 | -76 | -20 | 301 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/19 19:07  | 1/29/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 386 | 15.28 | 0 | 25 | 9 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/19 19:07  | 1/29/19  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.d | -1,391 | 55.09 | 0 | -25 | -8 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/30/18 20:10  | 11/28/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 250 | 13.86 | 0 | 18 | 7 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/30/18 20:10  | 11/28/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.d | -1,103 | 61.17 | 0 | -18 | -6 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/2/18 20:02  | 10/31/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 89 | 12.36 | 0 | 7 | 3 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/2/18 20:02  | 10/31/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.d | -470 | 65.10 | 0 | -7 | -2 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/18 20:10  | 9/28/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 312 | 12.36 | 0 | 25 | 9 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/1/18 20:10  | 9/28/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.d | -1,646 | 65.19 | 0 | -25 | -8 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/18 20:03  | 7/27/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/18 20:03  | 7/27/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -2,409 | 66.93 | 0 | -36 | -11 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/29/18 19:55  | 6/27/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/29/18 19:55  | 6/27/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -2,378 | 66.05 | 0 | -36 | -11 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/31/18 20:05  | 5/29/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/31/18 20:05  | 5/29/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -2,235 | 62.08 | 0 | -36 | -11 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/30/18 20:05  | 4/26/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/30/18 20:05  | 4/26/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -2,019 | 56.09 | 0 | -36 | -11 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/29/18 20:04  | 3/27/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/29/18 20:04  | 3/27/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,859 | 51.63 | 0 | -36 | -11 | 294 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/18 20:27  | 2/26/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 291 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/18 20:27  | 2/26/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,596 | 44.32 | 0 | -36 | -11 | 291 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/18 20:03  | 1/29/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 15 | 274 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/18 20:03  | 1/29/18  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,690 | 46.95 | 0 | -36 | -12 | 274 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/29/17 19:29  | 12/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 15 | 274 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/29/17 19:29  | 12/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,588 | 44.10 | 0 | -36 | -12 | 274 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/30/17 20:09  | 11/28/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/30/17 20:09  | 11/28/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,345 | 37.36 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/31/17 20:11  | 10/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/31/17 20:11  | 10/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,496 | 41.55 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/29/17 20:01  | 9/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/29/17 20:01  | 9/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,545 | 42.91 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/31/17 20:06  | 8/29/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/31/17 20:06  | 8/29/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,240 | 34.44 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/17 20:06  | 7/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/31/17 20:06  | 7/27/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,218 | 33.83 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/30/17 19:59  | 6/28/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/30/17 19:59  | 6/28/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -983 | 27.30 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/31/17 20:02  | 5/26/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 0 | 36 | 14 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/31/17 20:02  | 5/26/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -899 | 24.98 | 0 | -36 | -11 | 284 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/28/17 20:02  | 4/26/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 445 | 12.36 | 5 | 36 | 14 | 284 | D | 2 | 25 | 12 | 31 | 13 | 6 | 4 | 3 | 1 | 2 |  |  |  |  | 
4/28/17 20:02  | 4/26/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -870 | 24.16 | 5 | -36 | -11 | 284 | D | 2 | 25 | 12 | 31 | 13 | 6 | 4 | 3 | 1 | 2 |  |  |  |  | 
3/31/17 19:41  | 3/29/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 458 | 12.36 | 3 | 37 | 15 | 284 | D | -16 | 31 | 3 | 9 | 9 | 8 | 5 | 2 | 1 | 0 | 8 |  |  |  | 
3/31/17 19:41  | 3/29/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -834 | 22.50 | 3 | -37 | -12 | 284 | D | -16 | 31 | 3 | 9 | 9 | 8 | 5 | 2 | 1 | 0 | 8 |  |  |  | 
2/28/17 20:46  | 2/24/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 1,085 | 10.15 | 3 | 107 | 62 | 280 | D | -16 | 33 | 2 | -6 | 10 | 13 | 4 | 3 | 5 | 5 | 5 |  |  |  | 
2/28/17 20:46  | 2/24/17  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -2,287 | 21.39 | 3 | -107 | -28 | 280 | D | -16 | 33 | 2 | -6 | 10 | 13 | 4 | 3 | 5 | 5 | 5 |  |  |  | 
11/30/16 19:39  | 11/28/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 612 | 8.50 | 3 | 72 | 36 | 274 | D | -19 | 4 | 34 | 4 | 7 | 17 | 2 | -3 | -3 | -3 | -8 | -4 |  |  | 
11/30/16 19:39  | 11/28/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,648 | 22.89 | 3 | -72 | -21 | 274 | D | -19 | 4 | 34 | 4 | 7 | 17 | 2 | -3 | -3 | -3 | -8 | -4 |  |  | 
9/30/16 20:56  | 9/28/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.dm | 588 | 8.50 | 3 | 69 | 34 | 274 | D | -22 | 11 | 18 | 17 | -3 | 1 | -9 | -6 | -1 | -1 | -13 | -5 | 3 |  | 
9/30/16 20:56  | 9/28/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.dm | -1,505 | 21.76 | 3 | -69 | -20 | 274 | D | -22 | 11 | 18 | 17 | -3 | 1 | -9 | -6 | -1 | -1 | -13 | -5 | 3 |  | 
9/1/16 20:00  | 8/30/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 24 | 8.50 | 2 | 3 | 1 | 274 | D | -8 | 7 | 31 | 26 | 11 | -4 | 2 | 1 | -1 | 0 | 2 | 5 | 2 |  | 
9/1/16 20:00  | 8/30/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | S.d | -62 | 22.00 | 2 | -3 | -1 | 274 | D | -8 | 7 | 31 | 26 | 11 | -4 | 2 | 1 | -1 | 0 | 2 | 5 | 2 |  | 
2/23/16 17:45  | 2/19/16  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 51 | 13.91 | 5 | 4 | 1 | 254 | D | -46 | -41 | -27 | -28 | -16 | -14 | -2 | -1 | 7 | 3 | 16 | 6 | 40 | 39 | 
11/3/15 09:27  | 10/30/15  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 395 | 19.76 | 7 | 20 | 9 | 249 | D | -19 | -30 | -12 | -4 | 0 | 10 | 9 | 15 | 3 | 8 | 9 | -15 | -18 | -6 | 
7/28/14 11:58  | 7/24/14  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 482 | 24.12 | 6 | 20 | 10 | 223 | D | 42 | -21 | -27 | 10 | 1 | 5 | 7 | 2 | 2 | 4 | 4 | 14 | 7 | -3 | 
5/3/12 18:42  | 5/3/12  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 158 | 15.78 | 4 | 10 | 5 | 204 | D | 22 | 19 | -11 | 10 | -5 | -13 | -9 | -5 | 5 | 5 | -3 | -4 | 13 | 49 | 
3/21/12 21:10  | 3/19/12  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 165 | 16.55 | 2 | 10 | 5 | 194 | D | 27 | 40 | 10 | 4 | 16 | 16 | 2 | 2 | 6 | 9 | 8 | -8 | 8 | 41 | 
8/9/11 19:45  | 8/5/11  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 278 | 13.89 | 2 | 20 | 11 | 194 | D | -9 | -3 | -6 | -11 | -14 | -19 | -13 | -9 | -2 | 3 | 13 | 35 | 7 | 22 | 
6/9/11 19:09  | 6/7/11  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P.m | 151 | 15.07 | 3 | 10 | 6 | 174 | D | 8 | 43 | 12 | 24 | 23 | 3 | -1 | 3 | 3 | -1 | 4 | -3 | 14 | 0 | 
5/5/11 18:02  | 5/3/11  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P.m | 45 | 13.18 | 3 | 3 | 2 | 164 | D | 17 | 5 | 14 | -2 | 20 | 14 | 14 | 3 | -1 | 3 | 4 | 0 | 24 | 11 | 
1/5/11 21:48  | 1/3/11  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | M.d | 0 | 0.00 | 2 | 6 | 4 | 171 | D | 13 | 4 | 17 | 32 | 12 | 4 | 2 | 1 | -8 | -3 | -7 | -17 | 10 | 6 | 
6/14/10 20:47  | 6/10/10  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 214 | 10.68 | 6 | 20 | 14 | 166 | D | -35 | -22 | -16 | -21 | -26 | -6 | -5 | 2 | 9 | 10 | 16 | 1 | 21 | 43 | 
3/8/10 19:02  | 3/4/10  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 136 | 13.62 | 5 | 10 | 7 | 146 | D | -14 | 52 | -13 | 6 | -3 | 5 | 6 | 1 | 2 | 2 | 5 | -15 | -10 | -8 | 
8/7/09 17:00  | 8/7/09  | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bryant Douglas C | CA | DO | P,CEO | P | 138 | 13.80 | 5 | 10 | 10 | 110 |  |  |  |  |  |  |  |  |  | 7 | 9 | 16 | 4 | -7 | -9 |